Table 3.
Comparison of pulmonary function between moderate and severe patient groups.
| Moderate (n = 31) | Severe (n = 22) | t | p | |
|---|---|---|---|---|
| TLC (%) | 97.8 ± 11.8 | 99.5 ± 11.7 | −0.525 | 0.602 |
| FVC (%) | 97.8 ± 11.8 | 99.5 ± 11.7 | −0.525 | 0.602 |
| FEV1 (%) | 96.6 ± 13.5 | 98.5 ± 11.5 | −0.547 | 0.587 |
| FEV1/VCMAX% | 102.6 ± 6.7 | 103.2 ± 4.1 | −0.435 | 0.665 |
| FEF50 (%) | 89.1 ± 22.9 | 90.2 ± 19.2 | −1.77 | 0.86 |
| FEF75 (%) | 70.9 ± 29.8 | 73.9 ± 21.3 | −0.405 | 0.687 |
| MMEF (%) | 82.1 ± 23.5 | 83.7 ± 17.0 | −0.255 | 0.800 |
| DLCO-SB (%) | 83.7 ± 11.2 | 85.1 ± 12.1 | −0.425 | 0.673 |
DLCO-SB, diffusing capacity for carbon monoxide corrected for hemoglobin; FEF50, maximum expiratory flow at 50% FVC; FEF75, maximum expiratory flow at 75% FVC; FEV1, forced expiratory volume in one second; FVC, forced vital capacity; MMEF, maximum midexpiratory flow; TLC, total lung capacity; VCMAX%, maximum vital capacity percentage.